Irisin as an early marker for predicting gestational diabetes mellitus: a prospective study

References

• Perkins JM, Dunn JP, Jagasia SM. Perspectives in gestational diabetes mellitus: a review of screening, diagnosis, and treatment. Clin Diabetes 2007;25:57–62.
   Google Scholar
• Reece E. The fetal and maternal consequences of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2010;23:199–203.
   PubMed Web of Science ®Google Scholar
• Catalano PM. Trying to understand gestational diabetes. Diabet Med 2014;31:273–81.
   PubMed Web of Science ®Google Scholar
• Malcolm J. Through the looking glass: gestational diabetes as a predictor of maternal and offspring long-term health. Diabetes Metab Res Rev 2012;28:307–11.
   PubMed Web of Science ®Google Scholar
• Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012;481:463–8.
   PubMed Web of Science ®Google Scholar
• Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008;454:463–9.
   PubMed Web of Science ®Google Scholar
• Aydin S, Kuloglu T, Aydin S, et al. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides 2014;61:130–6.
   PubMed Web of Science ®Google Scholar
• Roca-Rivada A, Castelao C, Senin LL, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One 2013;8:e60563
   PubMed Web of Science ®Google Scholar
• Lee HJ, Lee JO, Kim N, et al. Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK. Mol Endocrinol 2015;29:873–81.
   PubMed Web of Science ®Google Scholar
• Staiger H, Böhm A, Scheler M, et al. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity. PLoS One 2013;8:e61903.
   PubMed Web of Science ®Google Scholar
• Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–82.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.
   PubMed Web of Science ®Google Scholar
• Bao W, Baecker A, Song Y, et al. Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: a systematic review. Metab Clin Exp 2015;64:756–64.
   PubMed Web of Science ®Google Scholar
• Stengel A, Hofmann T, Goebel-Stengel M, et al. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides 2013;39:125–30.
   PubMed Web of Science ®Google Scholar
• Pardo M, Crujeiras AB, Amil M, et al. Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int J Endocrinol 2014;2014:857270.
   PubMed Web of Science ®Google Scholar
• Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012;61:1725–38.
   PubMed Web of Science ®Google Scholar
• Crujeiras AB, Zulet MA, Lopez-Legarrea P, et al. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metab Clin Exp 2014;63:520–31.
   PubMed Web of Science ®Google Scholar
• Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013;98:769–78.
   PubMed Web of Science ®Google Scholar
• Hou N, Han F, Sun X. The relationship between circulating irisin levels and endothelial function in lean and obese subjects. Clin Endocrinol (Oxf) 2014;10: 339–43
   Google Scholar
• Liu JJ, Wong MD, Toy WC, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 2013;27:365–9.
   PubMed Web of Science ®Google Scholar
• Choi YK, Kim MK, Bae KH, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 2013;100:96–101.
   PubMed Web of Science ®Google Scholar
• Zhang M, Chen P, Chen S, et al. The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: a preliminary study. Eur Rev Med Pharmacol Sci 2014;18:1567–72.
   PubMed Web of Science ®Google Scholar
• Sanchis-Gomar F, Alis R, Pareja-Galeano H, et al. Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients. Endocrine 2014;46:674–7.
   PubMed Web of Science ®Google Scholar
• Sanchis-Gomar F, Alis R, Pareja-Galeano H, et al. Inconsistency in circulating irisin levels: what is really happening? Horm Metab Res 2014;46:591–6.
   PubMed Web of Science ®Google Scholar
• Garcés MF, Peralta JJ, Ruiz-Linares CE, et al. Irisin levels during pregnancy and changes associated with the development of preeclampsia. J Clin Endocrinol Metab 2014;99:2113–19.
   PubMed Web of Science ®Google Scholar
• Kuzmicki M, Telejko B, Lipinska D, et al. Serum irisin concentration in women with gestational diabetes. Gynecol Endocrinol 2014;30:636–9.
   PubMed Web of Science ®Google Scholar
• Ebert T, Stepan H, Schrey S, et al. Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery. Cytokine 2014;65:153–8.
   PubMed Web of Science ®Google Scholar
• Yuksel MA, Oncul M, Tuten A, et al. Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus. Diabetes Res Clin Pract 2014;104:171–5.
   PubMed Web of Science ®Google Scholar
• Piya MK, Harte AL, Sivakumar K, et al. The identification of irisin in human cerebrospinal fluid: influence of adiposity, metabolic markers, and gestational diabetes. Am J Physiol Endocrinol Metab 2014;306:E512–18.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Repiso C, Garcia-Serrano S, Rodriguez-Pacheco F, et al. FNDC5 could be regulated by leptin in adipose tissue. Eur J Clin Invest 2014;44:918–25.
   PubMed Web of Science ®Google Scholar